Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1039

1.

Detection of hypermethylated genes as markers for cervical screening in women living with HIV.

Kremer WW, Van Zummeren M, Novianti PW, Richter KL, Verlaat W, Snijders PJ, Heideman DA, Steenbergen RD, Dreyer G, Meijer CJ.

J Int AIDS Soc. 2018 Aug;21(8):e25165. doi: 10.1002/jia2.25165.

PMID:
30101434
2.

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.

Leeman A, Del Pino M, Marimon L, Torné A, Ordi J, Ter Harmsel B, Meijer CJLM, Jenkins D, Van Kemenade FJ, Quint WGV.

Int J Cancer. 2018 Aug 11. doi: 10.1002/ijc.31787. [Epub ahead of print]

PMID:
30098013
3.

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.

Verlaat W, van Leeuwen RW, Novianti PW, Schuuring E, Meijer CJLM, van der Zee AGJ, Snijders PJF, Heideman DAM, Steenbergen RDM, Wisman GBA.

Epigenetics. 2018 Aug 5. doi: 10.1080/15592294.2018.1507197. [Epub ahead of print]

PMID:
30079796
4.

Host cell DNA methylation markers for the detection of high-grade anal intraepithelial neoplasia and anal cancer.

van der Zee RP, Richel O, van Noesel CJM, Novianti PW, Ciocanea-Teodorescu I, van Splunter AP, Duin S, van den Berk GEL, Meijer CJLM, Quint WGV, de Vries HJC, Prins JM, Steenbergen RDM.

Clin Infect Dis. 2018 Jul 27. doi: 10.1093/cid/ciy601. [Epub ahead of print]

PMID:
30060049
5.

Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.

Swarts DRA, Voorham QJM, van Splunter AP, Wilting SM, Sie D, Pronk D, van Beurden M, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM, Bleeker MCG.

Cancer Med. 2018 Jul 20. doi: 10.1002/cam4.1633. [Epub ahead of print]

6.

Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions.

van Zummeren M, Leeman A, Kremer WW, Bleeker MCG, Jenkins D, van de Sandt M, Heideman DAM, Steenbergen R, Snijders PJF, Quint WGV, Berkhof J, Meijer CJLM.

J Clin Pathol. 2018 Jul 16. pii: jclinpath-2018-205271. doi: 10.1136/jclinpath-2018-205271. [Epub ahead of print]

7.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao.

Hooi DJ, Lissenberg-Witte BI, Kenter G, de Koning MNC, Gomes Bravio I, Ardts K, Kleinmoedig S, Benita E, Pinedo HM, Berkhof J, Quint WGV, Meijer CJLM.

PLoS One. 2018 Jul 13;13(7):e0199624. doi: 10.1371/journal.pone.0199624. eCollection 2018.

8.

Human papillomavirus (HPV) types prevalence in cervical samples of female sex-workers on Curaçao.

Hooi DJ, Quint WGV, Lissenberg-Witte BI, Kenter G, Pinedo HM, de Koning MNC, Meijer CJLM.

Prev Med Rep. 2018 Jun 2;11:120-124. doi: 10.1016/j.pmedr.2018.06.001. eCollection 2018 Sep.

9.

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.

Babion I, Snoek BC, Novianti PW, Jaspers A, van Trommel N, Heideman DAM, Meijer CJLM, Snijders PJF, Steenbergen RDM, Wilting SM.

Clin Epigenetics. 2018 Jun 7;10:76. doi: 10.1186/s13148-018-0509-9. eCollection 2018.

10.

Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls.

de Nijs J, Meijer JH, de Haan L, Meijer CJ, Bruggeman R, van Haren NEM, Kahn RS, Cahn W.

Psychiatry Res. 2018 Aug;266:147-151. doi: 10.1016/j.psychres.2018.05.009. Epub 2018 May 19.

PMID:
29864614
11.

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.

De Strooper LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, Snijders PJF, Meijer CJLM, Heideman DAM.

Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31539. [Epub ahead of print]

PMID:
29663363
12.

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, van Splunter AP, Peeters CFW, van Trommel NE, Massuger LFAG, Bekkers RLM, Melchers WJG, van Kemenade FJ, Berkhof J, van de Wiel MA, Meijer CJLM, Steenbergen RDM.

Clin Cancer Res. 2018 Jul 15;24(14):3456-3464. doi: 10.1158/1078-0432.CCR-17-3615. Epub 2018 Apr 9.

PMID:
29632006
13.

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.

Petry KU, Bollaerts K, Bonanni P, Stanley M, Drury R, Joura E, Kjaer SK, Meijer CJLM, Riethmuller D, Soubeyrand B, Van Damme P, Bosch X.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1800-1806. doi: 10.1080/21645515.2018.1450125. Epub 2018 May 24.

14.

High Whole-Genome Sequence Diversity of Human Papillomavirus Type 18 Isolates.

van der Weele P, Meijer CJLM, King AJ.

Viruses. 2018 Feb 7;10(2). pii: E68. doi: 10.3390/v10020068.

15.

High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women.

Donken R, King AJ, Bogaards JA, Woestenberg PJ, Meijer CJLM, de Melker HE.

J Infect Dis. 2018 Apr 23;217(10):1579-1589. doi: 10.1093/infdis/jiy067.

PMID:
29409034
16.

Supravaginal hysterectomy in Curaçao prevalence and impact on screening for cervical cancer.

Hooi DJ, Meijer CJLM, Witte BI, Bravio IG, Pinedo HM, Kenter GG.

Prev Med Rep. 2017 Nov 8;8:238-241. doi: 10.1016/j.pmedr.2017.11.005. eCollection 2017 Dec.

17.

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.

Hooi DJ, Lissenberg-Witte BI, de Koning MNC, Pinedo HM, Kenter GG, Meijer CJ, Quint WG.

Sex Transm Infect. 2018 Jun;94(4):263-267. doi: 10.1136/sextrans-2017-053109. Epub 2017 Oct 11.

18.

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.

Polman NJ, Oštrbenk A, Xu L, Snijders PJF, Meijer CJLM, Poljak M, Heideman DAM, Arbyn M.

J Clin Microbiol. 2017 Dec;55(12):3544-3551. doi: 10.1128/JCM.01282-17. Epub 2017 Oct 11.

19.

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test.

Polman NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, Meijer CJLM, Berkhof J.

Br J Cancer. 2017 Nov 7;117(10):1557-1561. doi: 10.1038/bjc.2017.309. Epub 2017 Sep 7.

PMID:
28881359
20.

An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.

Pos K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, Bruggeman R, Meijer CJ, de Haan L; for Group; Genetic Risk and Outcome of Psychosis investigators, Alizadeh BZ, Bartels-Velthuis AA, Van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NE, van Os J, van Winkel R.

Psychiatry Res. 2017 Dec;258:234-238. doi: 10.1016/j.psychres.2017.08.017. Epub 2017 Aug 18.

PMID:
28851542
21.

A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.

van Rooijen G, Isvoranu AM, Kruijt OH, van Borkulo CD, Meijer CJ, Wigman JTW, Ruhé HG, de Haan L; GROUP investigators.

Schizophr Res. 2018 Mar;193:232-239. doi: 10.1016/j.schres.2017.07.035. Epub 2017 Aug 23.

PMID:
28844638
22.

Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects.

Pos K, Meijer CJ, Verkerk O, Ackema O, Krabbendam L, de Haan L.

Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):57-64. doi: 10.1007/s00406-017-0833-7. Epub 2017 Aug 21.

23.

Longitudinal study of hippocampal volumes in heavy cannabis users.

Koenders L, Lorenzetti V, de Haan L, Suo C, Vingerhoets W, van den Brink W, Wiers RW, Meijer CJ, Machielsen M, Goudriaan AE, Veltman DJ, Yücel M, Cousijn J.

J Psychopharmacol. 2017 Aug;31(8):1027-1034. doi: 10.1177/0269881117718380. Epub 2017 Jul 25.

24.

Whole-Genome Sequencing and Variant Analysis of Human Papillomavirus 16 Infections.

van der Weele P, Meijer CJLM, King AJ.

J Virol. 2017 Sep 12;91(19). pii: e00844-17. doi: 10.1128/JVI.00844-17. Print 2017 Oct 1.

25.

Anal HPV 16 and 18 viral load: A comparison between HIV-negative and -positive MSM and association with persistence.

Marra E, King A, van Logchem E, van der Weele P, Mooij SH, Heijman T, Meijer CJLM, Verhagen DWM, van der Sande MAB, Schim van der Loeff MF.

J Med Virol. 2018 Jan;90(1):76-83. doi: 10.1002/jmv.24898. Epub 2017 Oct 17.

PMID:
28700080
26.

Selection of women at risk for cervical cancer in an HIV-infected South African population.

Van Zummeren M, Kremer WW, Van Aardt MC, Breytenbach E, Richter KL, Rozendaal L, Witte BI, De Strooper LMA, Hesselink AT, Heideman DAM, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

AIDS. 2017 Sep 10;31(14):1945-1953. doi: 10.1097/QAD.0000000000001583.

PMID:
28692545
27.

Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.

Veldhuijzen NJ, Polman NJ, Snijders PJF, Meijer CJLM, Berkhof J.

Int J Cancer. 2017 Oct 15;141(8):1551-1560. doi: 10.1002/ijc.30865. Epub 2017 Jul 18.

PMID:
28670823
28.

Human Papillomavirus Triage of Women With Atypical Squamous Cells of Undetermined Significance-Reduction of Overtreatment Needed.

Meijer CJLM, Snijders PJF.

JAMA Oncol. 2017 Oct 1;3(10):1310-1311. doi: 10.1001/jamaoncol.2017.1522. No abstract available.

PMID:
28654967
29.

Dopamine D2-receptor affinity of antipsychotics in relation to subjective well-being in patients with a psychotic disorder.

de Wit IE, van Dijk FA, Meijer CJ, van Tricht MJ, de Haan L; for GROUP.

Int Clin Psychopharmacol. 2017 Sep;32(5):249-255. doi: 10.1097/YIC.0000000000000182.

PMID:
28542034
30.

The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disorders.

Mansueto G, van Nierop M, Schruers K; GROUP Investigators, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NEM, van Os J, van Winkel R.

Schizophr Res. 2018 Feb;192:262-268. doi: 10.1016/j.schres.2017.04.003. Epub 2017 Apr 14.

PMID:
28416093
31.

Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequences.

Meijer CJLM, Steenbergen RDM.

Nat Rev Clin Oncol. 2017 Jul;14(7):397-398. doi: 10.1038/nrclinonc.2017.52. Epub 2017 Apr 11. No abstract available.

PMID:
28397825
32.

Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.

Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG.

Mod Pathol. 2017 Jul;30(7):1021-1031. doi: 10.1038/modpathol.2017.16. Epub 2017 Mar 17.

33.

A symptom network structure of the psychosis spectrum.

van Rooijen G, Isvoranu AM, Meijer CJ, van Borkulo CD, Ruhé HG, de Haan L; GROUP investigators.

Schizophr Res. 2017 Nov;189:75-83. doi: 10.1016/j.schres.2017.02.018. Epub 2017 Feb 22.

PMID:
28237606
34.

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.

Verlaat W, Snijders PJF, Novianti PW, Wilting SM, De Strooper LMA, Trooskens G, Vandersmissen J, Van Criekinge W, Wisman GBA, Meijer CJLM, Heideman DAM, Steenbergen RDM.

Clin Cancer Res. 2017 Jul 15;23(14):3813-3822. doi: 10.1158/1078-0432.CCR-16-2641. Epub 2017 Jan 24.

35.

Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.

Donken R, Schurink-Van't Klooster TM, Schepp RM, van der Klis FR, Knol MJ, Meijer CJ, de Melker HE.

J Infect Dis. 2017 Feb 1;215(3):359-367. doi: 10.1093/infdis/jiw588.

PMID:
28011916
36.

Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings.

Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L; GROUP investigators.

Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):279-289. doi: 10.1007/s00406-016-0751-0. Epub 2016 Dec 17.

37.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA Jr, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T; Psychosis Endophenotypes International Consortium, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J; CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium.

Nat Genet. 2017 Jan;49(1):27-35. doi: 10.1038/ng.3725. Epub 2016 Nov 21. Erratum in: Nat Genet. 2017 Sep 27;49(10 ):1558. Nat Genet. 2017 Mar 30;49(4):651.

38.

The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases.

Suijkerbuijk AW, Donken R, Lugnér AK, de Wit GA, Meijer CJ, de Melker HE, Bogaards JA.

Expert Rev Vaccines. 2017 Apr;16(4):361-375. doi: 10.1080/14760584.2017.1256778. Epub 2016 Nov 24. Review.

PMID:
27807989
39.

Immortalization capacity of HPV types is inversely related to chromosomal instability.

Schütze DM, Krijgsman O, Snijders PJ, Ylstra B, Weischenfeldt J, Mardin BR, Stütz AM, Korbel JO, de Winter JP, Meijer CJ, Quint WG, Bosch L, Wilting SM, Steenbergen RD.

Oncotarget. 2016 Jun 21;7(25):37608-37621. doi: 10.18632/oncotarget.8058.

40.

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.

Dijkstra MG, van Zummeren M, Rozendaal L, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, Meijer CJ, Berkhof J.

BMJ. 2016 Oct 4;355:i4924. doi: 10.1136/bmj.i4924. Erratum in: BMJ. 2016 Oct 27;355:i5782.

41.

The effect of childhood trauma and Five-Factor Model personality traits on exposure to adult life events in patients with psychotic disorders.

Pos K, Boyette LL, Meijer CJ, Koeter M, Krabbendam L, de Haan L, For Group.

Cogn Neuropsychiatry. 2016 Nov;21(6):462-474. doi: 10.1080/13546805.2016.1236014. Epub 2016 Sep 28.

PMID:
27678148
42.

Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.

Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ.

Int J Cancer. 2017 Jan 15;140(2):423-430. doi: 10.1002/ijc.30449. Epub 2016 Oct 11.

43.

Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women.

van der Weele P, van Logchem E, Wolffs P, van den Broek I, Feltkamp M, de Melker H, Meijer CJ, Boot H, King AJ.

J Clin Virol. 2016 Oct;83:6-11. doi: 10.1016/j.jcv.2016.07.020. Epub 2016 Aug 4.

PMID:
27522635
44.

Higher HPV16 and HPV18 Penile Viral Loads Are Associated With Decreased Human Papillomavirus Clearance in Uncircumcised Kenyan Men.

Senkomago V, Backes DM, Hudgens MG, Poole C, Meshnick SR, Agot K, Moses S, Snijders PJ, Meijer CJ, Hesselink AT, Schlecht NF, Bailey RC, Smith JS.

Sex Transm Dis. 2016 Sep;43(9):572-8. doi: 10.1097/OLQ.0000000000000500.

45.

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis.

Verlaat W, Snijders PJ, van Moorsel MI, Bleeker M, Rozendaal L, Sie D, Ylstra B, Meijer CJ, Steenbergen RD, Heideman DA.

J Pathol Clin Res. 2015 Sep 21;1(4):207-11. doi: 10.1002/cjp2.27. eCollection 2015 Oct.

46.

Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761].

Van Damme P, Bonanni P, Bosch FX, Joura E, Kjaer SK, Meijer CJLM, Petry KU, Soubeyrand B, Verstraeten T, Stanley M.

Vaccine. 2016 Sep 7;34(39):4759-4760. doi: 10.1016/j.vaccine.2016.07.035. Epub 2016 Jul 25. No abstract available.

47.

Management of high-risk HPV-positive women for detection of cervical (pre)cancer.

Luttmer R, De Strooper LM, Steenbergen RD, Berkhof J, Snijders PJ, Heideman DA, Meijer CJ.

Expert Rev Mol Diagn. 2016 Sep;16(9):961-74. doi: 10.1080/14737159.2016.1217157. Epub 2016 Aug 5. Review.

PMID:
27459506
48.

Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.

Uijterwaal MH, van Zummeren M, Kocken M, Luttmer R, Berkhof J, Witte BI, van Baal WM, Graziosi GCM, Verheijen RHM, Helmerhorst TJM, van Dijken DKE, Spruijt JWM, van Kemenade FJ, Fransen-Daalmeijer N, Bekker-Lettink M, Heideman DAM, Snijders PJF, Steenbergen RDM, Meijer CJLM.

Gynecol Oncol. 2016 Oct;143(1):135-142. doi: 10.1016/j.ygyno.2016.07.089. Epub 2016 Jul 16.

PMID:
27430395
49.

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.

Luttmer R, De Strooper LM, Dijkstra MG, Berkhof J, Snijders PJ, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ.

Br J Cancer. 2016 Aug 23;115(5):579-87. doi: 10.1038/bjc.2016.200. Epub 2016 Jul 14.

50.

A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men.

Van Damme P, Meijer CJLM, Kieninger D, Schuyleman A, Thomas S, Luxembourg A, Baudin M.

Vaccine. 2016 Jul 29;34(35):4205-4212. doi: 10.1016/j.vaccine.2016.06.056. Epub 2016 Jun 25.

Supplemental Content

Loading ...
Support Center